Bright Ideas - CIN Feasibility Study
ConditionAcute Lymphoblastic Leukemia (ALL)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-18
SponsorThe Hospital for Sick Children
About this trial
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Eligibility criteria
Qualifiers
Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)
newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy
English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)
without physical or cognitive impairments that preclude use of the PeNAT
Disqualifiers
None
Trial design
Treatments tested in this trial
- Bright Ideas - CIN Training
Treatment groups
75 Participants
are divided into 1 treatment groupSponsors and collaborators
The Hospital for Sick Children
Lead sponsor
Rutgers Cancer Institute of New Jersey
Collaborator
Inova Fairfax Hospital
Collaborator
Children's Hospital Los Angeles
Collaborator
Source ClinicalTrials.gov